Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome

Jie WANG; Xing-jiang XIONG; Yan-wei XING; Yong-mei LIU; Yan DONG; Lian DUAN; Jun LI

doi:10.13422/j.cnki.syfjx.20190845

您当前的位置：

首页 >

文章列表页 >

Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome

Monograph | 更新时间：2021-02-09

- Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 8, Pages: 1-6(2019)
- 作者机构：
  
  中国中医科学院　广安门医院，北京　 100053
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190845
  CLC： R24;R22;R541.4
- Received：02 March 2019，
  
  Published：20 April 2019
- 稿件说明：
移动端阅览
Jie WANG, Xing-jiang XIONG, Yan-wei XING, et al. Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 1-6.
DOI：

Jie WANG, Xing-jiang XIONG, Yan-wei XING, et al. Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 1-6. DOI： 10.13422/j.cnki.syfjx.20190845.

摘要

冠心病已成为严重危害人类健康的重大疾病，属于中医学中的“胸痹”“真心痛”范畴，而血瘀证为其核心病机，贯穿疾病始终。在30余年临床实践基础上，以“冠心病血瘀证”为研究对象，在“标准规范-分子机制-循证评价”方面开展全面、深入、系统研究，建立了冠心病血瘀证定量诊断标准，创新了中医证候定量化和客观化的研究方向，还从宏观表征到器官细胞分子水平揭示了冠心病血瘀证的生物学基础，将上述研究成果应用冠心病的防治中，提升了中医诊断准确率及冠心病的中医临床疗效。

Abstract

Coronary heart disease (CHD) has become a major disease that seriously endangers human health. It belongs to the category of " chest obstruction" and " genuine heart pain" in Chinese medicine

and blood stasis syndrome is its core pathogenesis of CHD

which runs through the disease all the time. On the basis of more than 30 years′ clinical practice and taking " blood stasis syndrome of CHD" as the research object

the research group has carried out a comprehensive

in-depth and systematic studies on diagnostic criteria

biological basis

and evidence-based evaluation. The quantitative diagnostic criteria of blood stasis syndrome of CHD were established

and the research directions of quantification and objectivity of Chinese medicine syndromes were innovated. The biological basis of blood stasis syndrome of CHD was revealed from macroscopic characterization to organ cell molecular level. When the above research results are applied in the prevention and treatment

the accuracy of diagnosis and the clinical efficacy for CHD has been improved in Chinese medicine.

关键词

Keywords

references

XIONG X J , WANG Z , WANG J. Innovative strategy in treating angina pectoris with Chinese patent medicines by promoting blood circulation and removing blood stasis: experience from combination therapy in Chinese medicine [J]. Curr Vasc Pharmacol , 2015 , 13 ( 4 ): 540 - 553 .

XIONG X J , Borrelli F , Ferreira A S , et al . Herbal medicines for cardiovascular diseases [J]. Evid Based Complement Alternat Med , 2014 , doi: 10.1155/2014/809741 doi:10.1155/2014/809741 .

王阶，陈可冀．论血瘀证的概念和范畴 [J]. 中国医药学报， 1989 , 4 ( 3 ): 7 - 9,79 .

王阶，陈可冀．中日两国对血淤证病因病机的认识 [J]. 辽宁中医杂志， 1991 , 18 ( 3 ): 44 - 47 .

王阶，陈可冀．血淤证古典辨证诊断探讨 [J]. 辽宁中医杂志， 1992 , 19 ( 3 ): 12 - 14 .

王阶，姚魁武，李军，等．冠心病“痰瘀滞虚”病机及临床研究 [J]. 中国中西医结合杂志， 2019 , doi: 10.7661/j.cjim.20190102.031 doi:10.7661/j.cjim.20190102.031 .

熊兴江．《伤寒论》与急危重症——基于CCU重症病例及中西医结合诠释经典条文内涵、经方剂量与六经实质 [J]. 中国中药杂志， 2018 , 43 ( 12 ): 2413 - 2430 .

WANG J , WANG P Q , XIONG X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine [J]. Int Med , 2012 , 2 : e1000113 .

WANG J , XIONG X J. Current situation and perspectives of clinical study in integrative medicine in China [J]. Evid Based Complement Alternat Med , 2012 , 2012 : e268542 .

王阶，陈可冀，翁维良，等．血瘀证诊断标准的研究 [J]. 中西医结合杂志， 1988 , 8 ( 10 ): 585 - 589 .

邢雁伟，王阶，衷敬柏，等．采用聚类分析和对应相关方法研究1069例冠心病心绞痛证候应证组合规律 [J]. 中华中医药杂志， 2007 , 22 ( 11 ): 747 - 750 .

李军，王阶．冠心病心绞痛证候要素与应证组合的5099例文献病例分析 [J]. 中国中医基础医学杂志， 2007 , 13 ( 12 ): 926 - 927,930 .

王阶，邢雁伟．冠心病心绞痛证候要素诊断标准 [J]. 中医杂志， 2018 , 59 ( 6 ): 539 - 540 .

王阶，李军，毛静远，等．冠心病心绞痛主要证型的辨证诊断标准 [J]. 中国中西医结合杂志， 2018 , 38 ( 2 ): 154 - 155 .

王阶，何庆勇．冠心病心绞痛血瘀证疗效评价标准 [J]. 中国实验方剂学杂志， 2018 , 24 ( 15 ): 1 - 3 .

王阶，何庆勇．冠心病心绞痛中医疗效评价标准 [J]. 中国实验方剂学杂志， 2018 , 24 ( 15 ): 7 - 10 .

杨保林，王阶，姜燕．冠心病血瘀证研究概况 [J]. 中国中医药信息杂志， 2003 , 10 ( 7 ): 86 - 87 .

姚魁武，王阶，朱翠玲，等．血瘀证患者实验室指标诊断贡献度比较研究 [J]. 世界中西医结合杂志， 2010 , 5 ( 1 ): 42 - 44,47 .

王阶，杨保林，姜燕．冠心病血瘀证相关基因研究 [J]. 世界科学技术—中医药现代化， 2005 , 7 ( 1 ): 16 - 19,135 .

WANG J , YU G. A systems biology approach to characterize biomarkers for blood stasis syndrome of unstable angina patients by integrating microRNA and messenger RNA expression profiling [J]. Evid Based Complement Alternat Med , 2013 , 2013 : e510208 .

王阶，滕菲，刘咏梅，等．血塞通对冠心病不稳定型心绞痛血瘀证患者microRNA的干预作用 [J]. 中国实验方剂学杂志， 2017 , 23 ( 19 ): 11 - 16 .

廖江铨，王阶，刘咏梅，等．高通量测序筛选冠心病血瘀证相关lncRNA-miRNA-mRNA调控网络 [J]. 中国实验方剂学杂志， 2017 , 23 ( 19 ): 28 - 33 .

段练．冠心病血瘀证相关miRNA表达的甲基化调控机制及生物标志物的研究 [D]．北京：北京中医药大学， 2018 .

王阶，许军，温林军，等．葛兰心宁对冠心病心绞痛患者中医证候疗效及血管内皮功能的影响 [J]. 中国医药学报， 2004 , 19 ( 10 ): 595 - 597 .

王阶，李霁，杨戈，等．活血化瘀药对不稳定性心绞痛患者纤溶活性的影响 [J]. 世界科学技术—中医药现代化， 2009 , 11 ( 2 ): 234 - 237 .

李霁，王阶，赵艳，等．活血化瘀药组分配伍对不稳定型心绞痛患者Fas系统的影响 [J]. 辽宁中医杂志， 2009 , 36 ( 7 ): 1128 - 1129 .

熊兴江．方证对应理论及其在冠心病心绞痛临床研究中的运用 [D]．北京：中国中医科学院， 2010 .

王师菡，王阶，李霁，等．丹蒌片治疗痰瘀互阻型冠心病心绞痛的疗效评价 [J]. 中国中西医结合杂志， 2012 , 32 ( 8 ): 1051 - 1055 .

熊兴江，姚魁武，禇福永，等．冠心病介入术后精神抑郁伴顽固性汗出治愈1例 [J]. 中医杂志， 2010 , 51 ( 9 ): 856 - 857 .

熊兴江，王阶．血府逐瘀汤方证特征 [J]. 中国中药杂志， 2011 , 36 ( 21 ): 3026 - 3031 .

褚福永，王阶，孙晓伟，等．血府逐瘀胶囊改善不稳定型心绞痛介入术后血瘀证患者近期生活质量的随机双盲对照试验 [J]. 中西医结合学报， 2009 , 7 ( 8 ): 729 - 735 .

XIONG X J . Integrating traditional Chinese medicine into Western cardiovascular medicine: an evidence-based approach [J]. Nat Rev Cardiol , 2015 , 12 ( 6 ): 374 .

王阶，邢雁伟，姚魁武，等．冠心病“痰瘀滞虚”理论内涵与外延 [J]. 中医杂志， 2019 , 60 ( 4 ): 280 - 284 .

王阶，陈光．基于复杂系统的冠心病痰瘀滞虚理论及临证应用 [J]. 中国实验方剂学杂志， 2019 , 25 ( 1 ): 11 - 15 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway

IL-6 Gene Promoter Methylation in Patients with Blood Stasis Syndrome and Unstable Angina

Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome

Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics

Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation

Related Author

LIU Yi

YANG Yang

SU Chang

TIAN Peng

WANG Mingyun

ZHONG Ruqian

XIE Xuejiao

YAN Qing

Related Institution

Hunan University of Chinese Medicine

Provincial Key Laboratory of Traditional Chinese Medicine（TCM） Diagnostics， Hunan University of Chinese Medicine

Hunan Traditional Chinese Medical College

School of Clinical Medicine，Beijing University of Chinese Medicine

Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰